Lloyd Price
FEBRUARY 2, 2024
Enhanced research efficiency: Researchers can gain faster access to anonymized patient data with patient consent through SSI, accelerating research efforts and drug development. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.
Lloyd Price
FEBRUARY 18, 2024
Interoperability and data analytics: Merging companies with expertise in connecting disparate healthcare systems and generating actionable insights can be valuable. AI and machine learning: Companies with advanced AI solutions for tasks like drug discovery, clinical trial optimisation, and personalised medicine can be attractive targets.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Lloyd Price
FEBRUARY 22, 2024
Corporate Development for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.
Lloyd Price
APRIL 29, 2024
Boost research and innovation: Researchers will have a secure platform to access and analyse large datasets for medical research, leading to advancements in disease prevention, treatment, and drug development. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions.
Healthcare IT Today
JANUARY 17, 2024
The Interoperability Year: More Technologies in the Marketplace Drive the Critical Need for Interoperability: In the rapidly evolving landscape of clinical trials and the myriad of technologies going to market, the imperative for interoperability will become increasingly evident.
Expert insights. Personalized for you.
64 
Let's personalize your content